Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-15 Sale |
2023-05-17 4:56 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $28.6 | $286,044 | 738,420 (Indirect Direct) |
View |
| 2023-04-20 Sale |
2023-04-24 7:10 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
25,000 | $25.15 | $628,720 | 4,794,384 (Indirect Direct) |
View |
| 2023-04-12 Sale |
2023-04-14 6:27 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $25.04 | $250,400 | 842,255 (Indirect Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 4:20 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,476 | $29.4 | $43,394 | 327,558 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 7:02 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,119 | $30.1 | $63,782 | 993,002 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 7:01 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
3,497 | $30.09 | $105,225 | 854,561 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 7:01 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
33,815 | $30.08 | $1,017,243 | 3,623,967 (Indirect Direct) |
View |
| 2023-02-10 Sale |
2023-02-14 7:06 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
3,366 | $30.03 | $101,071 | 329,034 (Indirect Direct) |
View |
| 2023-02-09 Sale |
2023-02-13 7:14 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
28,433 | $29.28 | $832,515 | 3,657,782 (Indirect Direct) |
View |
| 2023-02-08 Sale |
2023-02-10 6:12 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,521 | $30.88 | $46,968 | 332,400 (Indirect Direct) |
View |
| 2023-02-08 Sale |
2023-02-10 6:11 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
1,521 | $30.89 | $46,984 | 637,980 (Indirect Direct) |
View |
| 2023-02-08 Sale |
2023-02-10 6:10 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
1,377 | $30.88 | $42,522 | 995,121 (Indirect Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 5:09 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $29.53 | $295,339 | 738,438 (Indirect Direct) |
View |
| 2023-01-09 Sale |
2023-01-10 4:51 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,459 | $28.48 | $41,552 | 333,921 (Indirect Direct) |
View |
| 2023-01-05 Sale |
2023-01-09 9:43 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
4,087 | $28.52 | $116,568 | 335,380 (Indirect Direct) |
View |
| 2023-01-05 Sale |
2023-01-09 9:42 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,970 | $28.44 | $84,467 | 996,498 (Indirect Direct) |
View |
| 2023-01-05 Sale |
2023-01-09 9:41 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,636 | $28.44 | $74,968 | 639,501 (Indirect Direct) |
View |
| 2023-01-05 Sale |
2023-01-09 9:41 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
4,800 | $28.44 | $136,512 | 2,440,598 (Indirect Direct) |
View |
| 2023-01-04 Sale(A) |
2023-01-09 4:05 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,912 | $28.7 | $83,574 | 492,309 (Indirect) |
View |
| 2023-01-04 Sale |
2023-01-05 9:08 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,913 | $28.69 | $83,574 | 462,827 (Indirect Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 9:07 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,912 | $28.7 | $83,574 | 765,497 (Indirect Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 9:07 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
5,029 | $28.73 | $144,483 | 2,692,118 (Indirect Direct) |
View |
| 2022-11-23 Sale |
2022-11-28 7:30 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $30.48 | $609,600 | 2,107,225 (Indirect Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 5:37 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $30.27 | $605,463 | 2,127,225 (Indirect Direct) |
View |
| 2022-09-28 Sale |
2022-09-30 4:50 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $30.82 | $616,304 | 2,147,225 (Indirect Direct) |
View |
| 2022-08-23 Sale |
2022-08-25 6:11 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $31.61 | $632,282 | 2,167,225 (Indirect Direct) |
View |
| 2022-08-23 Sale |
2022-08-25 6:10 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,424 | $31.98 | $77,520 | 301,260 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:48 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,404 | $33.22 | $79,861 | 2,368,187 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:47 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,253 | $33.22 | $74,845 | 999,468 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:46 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,576 | $33.22 | $85,575 | 583,929 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-01 Option Award |
2023-06-05 6:07 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
16,865 | $0 | 1,009,867 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:06 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
16,865 | $0 | 2,124,090 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:05 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Klein Peter S Director |
16,865 | $0 | 28,178 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:04 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director |
16,865 | $0 | 28,178 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:04 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
16,865 | $0 | 85,642 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:03 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director |
16,865 | $0 | 353,178 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:02 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Harris Erik Director |
16,865 | $0 | 23,734 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:01 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director |
16,865 | $0 | 39,213 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 5:59 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
16,865 | $0 | 149,018 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 4:56 pm |
N/A 2027-03-07 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $0 | 738,420 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 4:56 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $5.28 | 738,420 (Indirect) |
View |
| 2023-04-20 Exercise |
2023-04-24 7:10 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
25,000 | $0 | 4,794,384 (Direct) |
View |
| 2023-04-20 Exercise |
2023-04-24 7:10 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
25,000 | $0.68 | 4,794,384 (Indirect) |
View |
| 2023-04-12 Exercise |
2023-04-14 6:27 pm |
N/A 2027-03-07 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $0 | 842,255 (Direct) |
View |
| 2023-04-12 Exercise |
2023-04-14 6:27 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $5.28 | 842,255 (Indirect) |
View |
| 2023-02-13 Exercise |
2023-02-15 7:01 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
25,000 | $0 | 854,561 (Direct) |
View |
| 2023-02-13 Exercise |
2023-02-15 7:01 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
25,000 | $0.68 | 854,561 (Indirect) |
View |
| 2023-02-13 Exercise |
2023-02-15 7:01 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
25,000 | $0 | 3,623,967 (Direct) |
View |
| 2023-02-13 Exercise |
2023-02-15 7:01 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
25,000 | $0.68 | 3,623,967 (Indirect) |
View |
| 2023-02-10 Exercise |
2023-02-13 7:14 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
25,000 | $0 | 3,657,782 (Direct) |
View |
| 2023-02-10 Exercise |
2023-02-13 7:14 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
25,000 | $0.68 | 3,657,782 (Indirect) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:09 pm |
N/A 2027-03-07 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $0 | 738,438 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:09 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $5.28 | 738,438 (Indirect) |
View |
| 2023-01-03 Option Award |
2023-01-05 9:08 pm |
N/A 2033-01-02 |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
164,480 | $0 | 462,827 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 9:07 pm |
N/A 2033-01-02 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
164,480 | $0 | 765,497 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 9:07 pm |
N/A 2033-01-02 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
328,960 | $0 | 2,692,118 (Direct) |
View |
| 2022-10-07 Exercise |
2022-10-12 4:05 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
20,000 | $0 | 824,007 (Direct) |
View |
| 2022-10-07 Exercise |
2022-10-12 4:05 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
20,000 | $0.68 | 824,007 (Indirect) |
View |